Steven A Shallcross's Net Worth

$926 Thousand

Estimate Recalculated Apr 5, 2024 04:08PM EST

Who is Steven A Shallcross?

Steven A Shallcross does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CYTOMEDIX INC, ADVANCIS PHARMACEUTICAL CORP, Vanda Pharmaceuticals Inc., Twin Vee PowerCats, Co., Elys Game Technology, Corp., and Theriva Biologics, Inc..

SEC CIK

Steven A Shallcross's CIK is 0001263501

Past Insider Trading and Trends

2007 was Steven A Shallcross's most active year for acquiring shares with 16 total transactions. Steven A Shallcross's most active month to acquire stocks was the month of November. 2007 was Steven A Shallcross's most active year for disposing of shares, totalling 38 transactions. Steven A Shallcross's most active month to dispose stocks was the month of December. 2022 saw Steven A Shallcross paying a total of $43,700.00 for 575,000 shares, this is the most they've acquired in one year. In 2006 Steven A Shallcross cashed out on 20,000 shares for a total of $264,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CYTOMEDIX INC (AURX) Snapshot price: $1.95

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+52.88%
27.5K
$0.38
$10,450.00
79.5K
Aug 26
Form 4
∞
52K
$0.39
$20,280.00
52K
Aug 20
Form 4/A
—
0
—
—
0
Apr 8
Form 4
—
0
—
—
0
Apr 8
Form 3
—
0
—
—
0
No matching records found

ADVANCIS PHARMACEUTICAL CORP No price found

SVP, CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 7
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
—
—
0
Feb 25
Form 3
—
0
—
—
0
No matching records found

Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $3.63

Sr. VP, CFO, Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
$5.84
-$20,841.85
0
Scheduled
Nov 28
Form 4
—
0
$10.31
-$50,310.85
0
Scheduled
Oct 16
Form 4
—
0
$8.80
-$40,014.85
3.3K
Scheduled
Sep 18
Form 4
—
0
$8.05
-$47,267.30
0
Scheduled
Aug 21
Form 4
—
0
$10.73
-$65,348.58
0
Scheduled
Jul 17
Form 4
—
0
$11.01
-$67,196.58
0
Scheduled
Jun 19
Form 4
—
0
$10.11
-$61,256.58
0
Scheduled
May 15
Form 4
—
0
$11.20
-$68,483.58
0
Scheduled
Apr 17
Form 4
—
0
$11.95
-$73,433.58
0
Scheduled
Mar 20
Form 4
—
0
$14.10
-$87,590.58
0
Scheduled
Feb 20
Form 4
—
0
—
—
0
Jan 30
Form 4
—
0
$13.09
-$80,886.18
0
Scheduled
Jan 16 - Nov 16
Form 4
—
0
$13.64
-$256,200.00
0
Dec 11
Form 3
—
0
—
—
0
No matching records found

Twin Vee PowerCats, Co. (VEEE) Snapshot price: $1.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 23
Form 3
—
0
—
—
0
No matching records found

Elys Game Technology, Corp. (ELYS) Snapshot price: $0.1971

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+428.45%
22.47K
$0.89
$20,000.08
27.72K
Feb 14
Form 4
—
0
—
—
0
Sep 13
Form 4
∞
5.25K
$5.72
$30,001.40
5.25K
Jan 22
Form 4
—
0
—
—
0
Oct 1
Form 4/A
—
0
—
—
0
Jul 5
Form 4
—
0
—
—
0
Jul 5
Form 3
—
0
—
—
0
No matching records found